Characterization of the mutation responsible for aspartylglucosaminuria in three Finnish patients. Amino acid substitution Cys163—-Ser abolishes the activity of lysosomal glycosylasparaginase and its conversion into subunits
Open Access
- 1 June 1991
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 266 (18) , 12105-12113
- https://doi.org/10.1016/s0021-9258(18)99071-x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Cloning and sequence analysis of a cDNA for human glycosylasparaginaseFEBS Letters, 1990
- ALTERNATIVE SPLICING IN THE CONTROL OF GENE EXPRESSIONAnnual Review of Genetics, 1989
- Expression of cDNA encoding the human “protective protein≓ associated with lysosomal β-galactosidase and neuraminidase: Homology to yeast proteasesCell, 1988
- The CpG dinucleotide and human genetic diseaseHuman Genetics, 1988
- Laboratory detection of aspartylglycosaminuriaScandinavian Journal of Clinical and Laboratory Investigation, 1988
- [71] Use of eukaryotic expression technology in the functional analysis of cloned genesPublished by Elsevier ,1987
- Aspartylglucosaminuria in the United StatesClinical Genetics, 1983
- Detection of heterozygotes for aspartylglucosaminuria (AGU) in cultured fibroblastsPublished by Springer Nature ,1974
- Glycoasparagine metabolites in patients with aspartylglycosaminuria: comparison between english and finnish patients with special reference to storage materialsClinica Chimica Acta; International Journal of Clinical Chemistry, 1973
- ASPARTYLGLYCOSAMINURIAThe Lancet, 1968